Angie Drakulich

Angie Drakulich was editorial director of BioPharm International.


Atypical Visible Particles: Can Users and Makers Find Common Ground?

In April 2012, industry experts discussed the issue of atypical visible particles in pharmaceutical raw materials, including excipients, at the joint International Pharmaceutical Excipient Council’s (IPEC) Regulatory Conference and ExcipientFest-Americas Conference in San Juan, Puerto Rico